• 011-26907444
  • raghava@iiitd.ac.in

Welcome to Peptide Card of AntiTbPdb

This page displays user query in tabular form.

FWGALAKGALKLIGSLFSSFSKKD details
Primary information
ID antitb_1187,
Name25019413
N-Terminal modificationPin2 [G]
C-Terminal ModificationFWGALAKGALKLIGSLFSSFSKKD
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature24
SourceL
OriginCationic
SpeciesSynthetic
StrainAmino acid substitution at one postion of Pin2 (P at 14 by G)
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis H37Rv
Cell LineMIC = 48.1 μg/ml or 18.7 μM
Inhibition ConcentrationIn vitro
Sequence2014
CytotoxicityRBC
In vivo ModelNA
Lethal DoseHemolysis ( IC-50 = 1.4 [0.4–4.3] )
Immune ResponceNone
Mechanism of ActionNA
TargetNA
Combination TherapyCell wall disruption
Other activitiesCell wall
PMIDNone
Year of PublicationAnti-bacterial (E. coli, S. aureus)
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1188,
Name25019413
N-Terminal modificationPin2 [G]
C-Terminal ModificationFWGALAKGALKLIGSLFSSFSKKD
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature24
SourceL
OriginCationic
SpeciesSynthetic
StrainAmino acid substitution at one postion of Pin2 (P at 14 by G)
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis muti-drug resistant strain (MDR) clinical isolate
Cell LineMIC = 48.1 μg/ml or 18.7 μM
Inhibition ConcentrationIn vitro
Sequence2014
CytotoxicityRBC
In vivo ModelNA
Lethal DoseHemolysis ( IC-50 = 1.4 [0.4–4.3] )
Immune ResponceNone
Mechanism of ActionNA
TargetNA
Combination TherapyCell wall disruption
Other activitiesCell wall
PMIDNone
Year of PublicationAnti-bacterial (E. coli, S. aureus)
Tertiary Structure
(Technique)
Not Predicted),